RE:RE:ShiseidoIt is my understanding that both companies were to run trials at the same time and share data at the end. Replicel contends that there wasn't any time frame (we could run it in 2014 or 2024) but Shiseido must share their data. Shiseido thinks Replicel is in breach. Not sure what Replicel has done with all the money raised since 2013. To me the only thing that matters in that RCH-01 works.....royalties would be nice but the interest generated from positive results would propel the stock price significantly higher